Jane Street Group, LLC Soleno Therapeutics Inc Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.14 - $0.23 $1,959 - $3,219	-13,998 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.22 - $0.47 $1,302 - $2,783	-5,922 Reduced 29.73%	13,998 $3,000
Q4 2021 Feb 15, 2022	BUY	$0.41 - $0.91 $8,167 - $18,127	19,920 New	19,920 $8,000
Q3 2020 Nov 17, 2020	SELL	$1.71 - $2.51 $96,738 - $141,995	-56,572 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.77 - $4.23 $100,132 - $239,299	56,572 New	56,572 $125,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.